Apritant 150mg Injection
By Apritant
Rx
1 Injection in a Vial

Composition
Fosaprepitant(150mg)

Manufacturer - MSN Laboratories
MSN House, Plot No: C-24, Industrial Estate, Sanathnagar, Hyderabad - 18 Telangana, INDIA

Expires on or after
July, 2025

liver
Apritant 150mg Injection should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of Apritant 150mg Injection in these patients. It is important to consult a healthcare professional before using this medication. However, no dose adjustment is typically required for individuals with moderate to severe liver disease. If you have any concerns about how your liver condition may affect the use of Apritant 150mg Injection, it's best to seek advice from your healthcare provider.

kidney
Apritant 150mg Injection can be used safely in patients with kidney disease. It is not necessary to adjust the dose of Apritant 150mg Injection for patients with kidney issues.

alcohol
It is unsafe to consume alcohol with Apritant 150mg Injection.

driving
Apritant 150mg Injection might reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Apritant 150mg Injection is generally safe to use during pregnancy. Animal studies found minimal harm to the baby, but human studies are limited.

breastfeeding
Apritant 150mg Injection may not be safe to use during breastfeeding as it may pass into breastmilk and harm the baby. Limited human data is available on this.
Habit Forming | No |
Chemical Class | Phenylmorpholine Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | NK1 Antagonists |
₹2964.6
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024